» Articles » PMID: 32587838

Proliferation, Characterization and Differentiation Potency of Adipose Tissue-Derived Mesenchymal Stem Cells (AT-MSCs) Cultured in Fresh Frozen and Non-Fresh Frozen Plasma

Abstract

Mesenchymal stem cells (MSCs) have unique properties, including high proliferation rates, self-renewal, and multilineage differentiation ability. Their characteristics are affected by increasing age and microenvironment. This research is aimed to determine the proliferation, characteristics and differentiation capacity of adipose tissue-derived (AT)-MSCs at many passages with different media. The cell proliferation capacity was assayed using trypan blue. MSCs characterization (CD90, CD44, CD105, CD73, CD11b, CD19, CD34, CD45, and HLA-DR) was performed by flow cytometry, and cell differentiation was determined by specific stainings. Population doubling time (PDT) of AT-MSCs treated with fresh frozen plasma (FFP) and non-FFP increased in the late passage (P) (P15 FFP was 22.67 ± 7.01 days and non-FFP was 19.65 ± 2.27 days). Cumulative cell number was significantly different between FFP and non-FFP at P5, 10, 15. AT-MSCs at P4-15 were positive for CD90, CD44, CD105, and CD73, and negative for CD11b, CD19, CD34, CD45, and HLA-DR surface markers. AT-MSCs at P5, 10, 15 had potential toward adipogenic, chondrogenic, and osteogenic differentiation. Therefore, PDT was affected by increased age but no difference was observed in morphology, surface markers and differentiation capacity among passages. Cumulative cell number in FFP was higher in comparison with non-FFP in P5, 10, 15. Our data suggest that FFP may replace FBS for culturing MSCs.

Citing Articles

The Potential of Human Wharton's Jelly Mesenchymal Stem Cells Secretome Based Topical Gel for Therapeutic Application.

Widowati W, Faried A, Gunanegara R, Rahardja F, Zahiroh F, Sutendi A Avicenna J Med Biotechnol. 2024; 16(4):233-243.

PMID: 39606678 PMC: 11589430. DOI: 10.18502/ajmb.v16i4.16739.


Non-Cytotoxic Graphene Nanoplatelets Upregulate Cell Proliferation and Self-Renewal Genes of Mesenchymal Stem Cells.

Nicoletti N, Marinowic D, Perondi D, Goncalves J, Piazza D, Da Costa J Int J Mol Sci. 2024; 25(18).

PMID: 39337305 PMC: 11431873. DOI: 10.3390/ijms25189817.


The potency of mesenchymal stem/stromal cells: does donor sex matter?.

Maged G, Abdelsamed M, Wang H, Lotfy A Stem Cell Res Ther. 2024; 15(1):112.

PMID: 38644508 PMC: 11034072. DOI: 10.1186/s13287-024-03722-3.


An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration.

Malicev E, Jazbec K Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543135 PMC: 10975472. DOI: 10.3390/ph17030350.


Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment.

Ghufran H, Azam M, Mehmood A, Umair M, Baig M, Tasneem S J Clin Exp Hepatol. 2024; 14(4):101364.

PMID: 38449506 PMC: 10912848. DOI: 10.1016/j.jceh.2024.101364.


References
1.
Ayatollahi M, Talaei-Khozani T, Razmkhah M . Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs. Iran J Basic Med Sci. 2016; 19(2):145-53. PMC: 4818361. View

2.
Atashi F, Modarressi A, Pepper M . The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 2015; 24(10):1150-63. PMC: 4424969. DOI: 10.1089/scd.2014.0484. View

3.
Yamamoto N, Isobe M, Negishi A, Yoshimasu H, Shimokawa H, Ohya K . Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci. 2003; 50(1):63-9. View

4.
Sun X, Nong J, Qin K, Warnock G, Dai L . Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. World J Stem Cells. 2011; 3(11):96-103. PMC: 3240679. DOI: 10.4252/wjsc.v3.i11.96. View

5.
Bieback K . Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfus Med Hemother. 2013; 40(5):326-35. PMC: 3822281. DOI: 10.1159/000354061. View